Drug Interaction with Radiopharmaceuticals: A Review

Brazilian Archives of Biology and Technology

Volumn 48, Issue SPECIL ISS. 2, 2005, Pages 13-27

  Bernardo Filho, Mario ^a,b   Santos Filho, Sebastião David ^a,c   de Moura, Egberto Gaspar ^a   Maiworm, Adalgisa Ieda ^a,d   Orlando, Margarida Maria de Camões ^e   Penas, Maria Expósito ^f   Cardoso, Valbert Nascimento ^g   Bernardo, Luciana Camargo ^a   Brito, Lavínia de Carvalho ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c Centro Universitario de Volta Redonda   (Brazil)

^d HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^e Setor de Medicina Nuclear   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bioavailability; Blood constituents; Drug interaction; Radiobiocomplexes

Indexed keywords

EID: 33751377458     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132005000700003     Document Type: Review

References (86)

1. Bacher, K. and Thierens, H. M. (2005), Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine. Nucl. Med. Commun., 26, 581-586.
2. -99m. Arq. Biol. Tecnol., 29, 407-412.
3. Bilgi, C.; Brown, N. E.; McPherson, T. A. and Lentle, B. (1979). Pulmonary manifestations in patients with malignant melanoma during BCG immunotherapy. A preliminary report. Chest, 75, 685-687.
4. -99m. Curr Pharm Design, 6, 1179-1191.
5. 99mTc-DTPA in Balb/c mice. J. Exp. Clin. Cancer Res., 17, 313-316.
6. Buchsbaum, M. S.; Potkin, S.; Siegel, B.; Bunney, W. E.; Lohr, J.; Katz, M.; Gottschalk, L.; Lottenberg, S.; Teng, C. and Abel, L. (1992), PET studies of drug interaction with brain regional glucose metabolism. Clin Neuropharmacol. 15, 472A-473A.
7. -99m: role of band-3 protein in the transport of pertechnetate across the cell membrane. J. Nucl. Med., 31, 2004-2008.
8. -99m and on the biodistribution of sodium pertechnetate in rats. Cell. Mol. Biol., 48, 771-776.
9. Cardoso, V.; Roca, M. and Martin-Comin, J. (2002), No influence of propanolol, cyclosporine, adriamycin, and nifedipine on the in vitro labeling of erythrocytes. Rev. Esp. Med. Nucl., 21, 24-27.
10. Carlsson, S. (1995), A glance at the history of nuclear medicine. Acta. Oncol., 34, 1095-1102.
11. th ed. New York: Williams & Wilkins.
12. 99mTc-methylene diphosphonate (MDP)-gentamicin interaction. J. Nucl. Biol. Med., 38, 132-134.
13. Choy, D.; Murray, I. P. and Hoschl, R. (1981), The effect of iron on the biodistribution of bone scanning agents humans. Radiol., 140, 197-202.
14. -99m stannous pyrophosphate following direct current transthoracic countershock. Circulation., 54, 980-986.
15. DeGraaf, P.; Pauwels, E. K. J. and Schicht, I. M. (1979), Scintigraphy detection of gastric calcification in dialysis patients. Diagn. Imaging, 48, 171-176.
16. -99m and on the morphometry of red blood cells. J. Label. Compds. Radiophars., 44, S648-S650.
17. 99mTechnetium. Nature and Science, 2, 6-10.
18. -99m and on the biodistribution of the radiopharmaceutical sodium pertechnetate in mice: an in vitro and in vivo analysis. Pakistan. J. Nutrit., 2, 221-227.
19. Early, P. J. and Sodee, D. B. (1996), Principles and Practice of Nuclear Medicine. Toronto: Mosby - Year Book Inc.
20. Eising, E. G. and Sciuk, J. (1995), Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur. J. Nucl. Med., 22, 587.
21. Goldfarb, C. R.; Shah, P. J. and Jay, M. (1979), Extraosseous uptake of bone-seeking tracers: an expected but unsuspected addition to the list. Clin Nucl Med., 4, 194-195.
22. 99m Technetium-phytic acid in mice: a model to evaluate the toxic effect of a chemical drug. J. Appl. Toxicol., 22, 85-87.
23. -99m-methylenediphosphonic acid in balb/c mice. Nucl. Med. Commun., 19, 1177-1179.
24. Gomes, M. L.; Mattos, D. M. M.; Freitas, R. S.; Bezerra, J. R. A. C. and Bernardo-Filho, M. (2001), Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations. Hum. Exp. Toxicol., 20, 193-197.
25. 99m-labelled sodium pyrophosphate in mice. Cell. Mol. Biol., 48, 757-760.
26. -99m and on the bioavailability of radiopharmaceuticals. Braz. Arch. Biol Technol., 45, 143-149.
27. 99mTc pertechnetate scanning. Ann. Intern. Med., 97, 55-58.
28. Harbert, J. C.; Eckelman, W. C. and Neumann, R. D. (1996), Nuclear Medicine Diagnosis and therapy. New York: Thieme Medical Publishers.
29. Hakim, S. G.; Jacobsen, H. C. H.; Hermes, D.; Kosmehl, H.; Lauer, I.; Nadrowitz, R. and Sieg, P. (2004), Early Immunohistochemical and functional markers indicating radiation damage of the parotid gland. Clin. Oral Investig., 8, 30-35.
30. Hesslewood, S. and Leung, E. (1994), Drug interactions with radiopharmaceuticals. Eur. J. Nucl. Med., 21, 348-356.
31. Hladik III, W. B.; Saha, G. B. and Study, K. T. (1987), Essentials of Nuclear Medicine Science. London: William and Wilkins.
32. Hojelse, C.; Kristensen, K. and Sampson, C. B. (1994), In: Sampson, C. B. (Ed.). Textbook of Radiopharmacy - Theory and Practice. London.
33. Hung, G. L.; James, A. P. and Hammes, R. J. (1996), Radiopharmaceuticals related pitfalls and artifacts. Semin. Nucl. Med., 26, 208-255.
34. Hurley, P. J. (1972), Patent formamen ovale demonstrated by lung scanning. J. Nucl. Med., 13, 177-179.
35. Jankovic, D. L. J. and Djokic, D. D. J. (2005), Alteration of the organ uptake of the (99m)Tc radiopharmaceuticals, (99m)Tc-DPD, (99m)Tc- DMSA, (99m)Tc-tin colloid and (99m)Tc MAA, induced by the applied cytotoxic drugs methotrexate sodium and cyclophosphamide. Nucl Med Commun., 26, 415-419.
36. 99mTc-pyrophosphate in breast prothesis. Clin. Nucl. Med., 2, 452-453.
37. 99mTc-DTPA radioaerosol inhalation lung scan. Nucl. Med. Commun., 24, 825-828.
38. Kumakura, Y.; Danielsen, E. H.; Reilhac, A.; Gjedde, A. and Cumming, P. (2004), Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurol Scand., 110, 188-195.
39. -99m pyrophosphate tomography. Eur. J. Nucl. Med., 22, 1286-91.
40. -99m binding by red blood cells: concise communication. J. Nucl. Med., 24, 397-401.
41. -99m and on the survival of Escherichia coli AB1157 submitted to the treatment with stannous chloride. Food Chem. Toxicol., 40, 919-923.
42. Lutrin, C. L. and Goris, M. L. (1979), Pyrophosphate retention by previously irradiated renal tissue. Radiol., 133, 207-209.
43. 99mTc-phytate in Balb/c mice. In: Nicolini, M. and Mazzi, U. (Eds.). Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine. Podova: Servizi Grafici Editoriali. pp. 465-472.
44. Mattos, D. M. M.; Gomes, M. L.; Freitas, R. S.; Cardoso, V. N. and Bernardo-Filho, M. (2001), Drug interaction with radiopharmaceuticals and the importance for the radiation dose to the patient. In: IAEA (Eds.). Radiological protection of patients in diagnostic and interventional radiology, nuclear medicine and radiotherapy. Vienna, Austria.
45. Mattos, D. M. M.; Gomes, M. L.; Freitas, R. S.; Rodrigues, P. C.; Paula, E. F. and Bernardo-Filho, M. (1999b), A model to evaluate the biological effect of natural products: vincristine action on the biodistribution of radiopharmaceuticals in Balb/c female mice. J. Appl. Toxicol., 19, 251-254.
46. -99m. J. Label. Compd. and Radioph., 44, S639-S641.
47. Moreno, S.; Carvalho, J. J.; Nascimento, A. L. R.; Freitas, R. S.; Diré, G.; Lima, E.; Lima-Filho, G.; Rocha, E. K. and Bernardo-Filho, M. (2004), Biodistribution of sodium pertechnetate and light microscopy of organs isolated from the rats: study of the effects of a Ginkgo biloba extract. Pakistan Journal of Nutrition, 3, 64-67.
48. -99m MDP after radiation therapy for cancer of the breast. Clin. Nucl. Med., 20, 770-771.
49. -99m. Cell. Mol. Biol. (Noisy-le-grand), 48, 793-801.
50. 99mTc-DTPA radioaerosol inhalation lung scan following blunt chest trauma. Ann. Nucl. Med., 18, 573-577.
51. -99m. Yale J. Biol. Med., 69, 489-494.
52. -99m. J. Ethnopharmacol., 72, 179-184.
53. -99m and on the morphology of red blood cells: I - a study with Paullinia cupana. Fitoterapia, 73, 305-312.
54. -99m and the histological modifications on the shape of the red blood cells. Food and Chemical Toxicology, 41,15-20.
55. -99m and on the morphology of red blood cells (RBC): toxicological action of roast coffee beans (Coffea arabica). Indian J. Nucl. Med., 18, 52-56.
56. Owunwanne, A.; Patel, M. and Sadek, S. (1995), Preparation of radiopharmaceuticals. The handbook of radiopharmaceuticals. London: Chapman & Hall.
57. Owunwanne, A.; Shihab-Eldeen, A.; Yacoub, T. and Ziada, G. (1998), The use of radiopharmaceuticals as an effective toxicologic technique for studying nephrotoxicity of drugs: cyclosporine-A. Hum. Exp. Toxicol., 17, 613-619.
58. Passos, M. C. F.; Ramos, C. F.; Bernardo-Filho, M.; Mattos, D. M. and Moura, E. G. (2000), The effect of protein or energy restriction on the biodistribution of Na99mTcO4 in Wistar rats. Nucl. Med. Comm., 21, 1059-1062.
59. Passos, M. C. F.; Ramos, C. F.; Dutra, S. C. P.; Bernardo-Filho, M. and Moura, E.G. (2002), Biodistribution of Na99mTcO4 changes in adult rats whose mothers were malnourished during lactation. J. Nucl. Med., 43, 89-91.
60. Perkins, A. and Frier, M. (1999), Nuclear Medicine in Pharmaceutical Research. Taylor & Francis, London.
61. -99m stannous pyrophosphate myocardial scintigrams. Circulation., 54, 399-403.
62. -99m binding to the red blood cell: concise communication. J. Nucl. Med., 21, 676-678.
63. -99m. App. Radiat. Isot., 51, 145-149.
64. Saha, G. B. (2004), Fundamentals of nuclear pharmacy. New York: Springer-Verlag.
65. Sampson, C. B. (1993), Adverse reactions and drug interactions with radiopharmaceuticals. Drug Safety., 8, 280-294.
66. Sampson, C. B. (1996), Complications and difficulties in radiolabelling blood cells: A review. Nucl. Med. Comm., 17, 648-658.
67. Sampson, C. B. (1999), Textbook of radiopharmacy theory and practice. Amsterdam: Gordon and Breach.
68. 99mTc-MDP to blood cells and plasma proteins. Braz. J. Med. Biol. Res., 28, 131-135.
69. -99m e na biodisponibilidade do radiofármaco pertecnetato de sódio em ratos Wistar. Acta Cir. Bras., 20, 121-125.
70. -99m: a possible evaluation of free radicals. J. Biol. Sci., 4, 266-270.
71. 99mTcsodium pertechnetate in Wistar rats. World J. Nucl. Med., 3, 235.
72. -99m pyrophosphate accumulation on prothetic valves. Clin. Nucl. Med., 5, 367-369.
73. 99mTc pyrophosphate in chest wall tissues due to defibrillation. Clin. Nucl. Med., 2, 6-7.
74. 99mTc-(Sn)- pyrophosphate following irradiation of the chest. Radiology, 124, 165-168.
75. Sorkin, S. J.; Horij, S. C. and Passalaqua, A. [19--], Augmented activity on a bone scan following local chemoperfusion. Clin. Nucl. Med., 2, 451.
76. -99m using the UltraTag RBC kit. J. Nucl. Med. Technol., 27, 132-135.
77. -99m-tin-RBC labeling reactions. J. Label. Comp. Radioph., 21, 1055.
78. 99mTc-DTPA radioaerosol transalveolar clearance in irradiated canine lung. J. Nucl. Med., 42, 292-299.
79. -99m red blood cell labeling. Iodinated contrast media. Clin. Nucl. Med., 8, 585-587.
80. Turranoglu, S.; Kaya, S.; Kararmaz, A. and Turhanoglu, A. D. (2001), Lung perfusion in hemorrhagic shock of rats: the effects of resuscitation with whole blood, saline or Hes 6%. Tohoku J. Exp. Med., 195, 245-251.
81. -99m pertechnetate to erythrocytes in a patient receiving multiple pharmaceuticals. Clin. Nucl. Med., 25,152-153.
82. Valenca, S. S.; Lima, E. A.; Dire, G. F.; Bernardo- Filho, M. and Porto, L. C. (2005), Sodium pertechnetate (Na99mTcO4) biodistribution in mice exposed to cigarette smoke. BMC Nucl. Med., 11, 1.
83. Velchik, M. G.; Kramer, F. M.; Stunkard, A. J. and Alavi, A. (1989), Effect of the Garren-Edwards gastric bubble on gastric emptying. J. Nucl. Med., 30, 692-6.
84. -99m. J. Exp. Clin. Cancer Res., 17, 1-6.
85. -99m methylene diphosphonate after radiation therapy. J. Nucl. Med., 20, 32-34.
86. Wolfstein, R. S.; Tanasescu, D. E.; Waxman, A. D. and Siemsen, J. K. (1976), Transient brain scan abnormalities in renal dialysis patients. J. Nucl. Med., 17, 6-8.